A high level overview of SigmaCERF Features and Benefits. Link to brochure
Pharmaceutical R&D and Electronic Lab Notebooks - An Unbeatable Team
So what are the benefits of
a well designed, well implemented electronic laboratory
notebook ? Link
to white paper
Walk, Don't Run - Why you
Need to buy an ELN Today!
Some compelling reasons as
to why an ELN is not just useful,
but essential , to
any organization that wants
to stay competitive in the
modern world of science. Link
to white paper
SigmaCERF Features & Benefits
for the Scientist
SigmaCERF is a highly usable
and useful product that offers
the features you need to improve
research performance throughout
your organization Link
to white paper
It's Academic: Data
Portability and ELNs
The Life Sciences are slowly
but surely making the move
into Electronic Lab Notebooks
(ELNs), and while much attention
has been focused on the barriers
to entry into ELNs,
so far little has been spent
on the flip side of that coin
- getting data back out of
an ELN. Link
to white paper
ELN Activation Energy: The
Top 10 Reasons Users Won't
Use Your ELN & How to Overcome
Them
The last thing that a organization
needs to discover is that the
new system they've purchased
being used by the very scientists
the ELN is there to help. This
article will go over the top
10 barriers to adoption and
describe some strategies to
overcoming them. Link
to white paper
Browser-based vs. Client-Server-based
ELNs - which is right for you?
There are many Electronic
Lab Notebooks on the market,
and picking the right one for
you can be confusing. Link
to white paper
This plugin architecture enables us to display sequence traces or sequence files directly inline, not as file icons that need to be opened in a separate application, nor as static images - the plug-in architecture allows CERF to dynamically display and browse . Link to white paper
Compliance with FDA regulations places a substantial burden on your organization. This document details how CERF complies with the various requirements of 21 CFR Part 11.Link to white paper
The R&D landscape is changing for the life sciences industry and it is increasingly important to collaborate to carry out key activities across the drug development lifecycle. Partnerships of many sorts can deliver tremendous benefits. Link to white paper
